Cord Blood News Volume 13.15 | Apr 29 2021

    0
    89







    2021-04-29 | CBN 13.15


    Cord Blood News by STEMCELL Technologies
    Vol. 13.15 – 29 April, 2021
    TOP STORY

    HucMSC Exosome-Delivered 14-3-3ζ Alleviates Ultraviolet Radiation-Induced Photodamage via SIRT1 Pathway Modulation

    To investigate the functions of exosomes derived from human umbilical cord MSC (hucMSC-ex) in a rat model of acute skin photodamage, immunofluorescence and immunohistochemical staining, quantitative real-time-polymerase chain reaction, western blot, and gene silencing assays were performed.
    [Aging]

    Full Article

    Dr. Jackie Damen discusses why the CFU assay should be a vital part of your cell therapy workflow in this on-demand webinar.
    PUBLICATIONSRanked by the impact factor of the journal

    Establishment of a Vietnamese Ethnicity Induced Pluripotent Stem Cell Line (VRISGi001-a) from Umbilical Cord Blood Hematopoietic Stem Cells under a Feeder-Free System

    Researchers established the original footprint-free Vietnamese human induced pluripotent stem cell line, VRISGi001-A, from cord-blood derived CD34+ hematopoietic stem cells of a 35 year old healthy woman under cGMP-compliant process.
    [Stem Cell Research]

    Full Article

    Prenatal Transplantation of Human Amniotic Fluid Stem Cell Could Improve Clinical Outcome of Type III Spinal Muscular Atrophy in Mice

    Motor function was analyzed by three behavioral tests. Engraftment of human amniotic fluid stem cell in organs were assessed by flow cytometry and RNA scope.
    [Scientific Reports]

    Full Article

    Vascular Dysfunction after Modeled TBI Is Rescued with Administration of Umbilical Cord Derived Stromal Cells and Is Associated with Modulation of the Angiogenic Response

    Investigators hypothesized that the perivascular properties of human umbilical cord perivascular cells could reduce vascular dysfunction after modelled traumatic brain injury by preserving the pericyte-endothelial interactions.
    [Journal of Neurotrauma]

    Abstract

    Microvesicles Derived from Human Umbilical Cord Mesenchyme Promote M2 Macrophage Polarization and Ameliorate Renal Fibrosis Following Partial Nephrectomy via Hepatocyte Growth Factor

    Scientists investigated whether icrovesicles derived from human Wharton’s jelly MSCs regulated macrophage polarization and ameliorated renal fibrosis following ischemia-partial nephrectomy via transferring hepatocyte growth factor.
    [Human Cell]

    Abstract

    Minicircle-Based Expression of Vascular Endothelial Growth Factor (VEGF) in Mesenchymal Stromal Cells (MSC) from Diverse Human Tissues

    Researchers compared the angiogenic potential of MSCs obtained from bone marrow, adipose tissue and umbilical cord matrix that were genetically modified with VEGF‐encoding minicircle vectors.
    [Journal of Gene Medicine]

    Abstract

    Type 2 Alveolar Epithelial Cells Differentiated from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Mouse Pulmonary Fibrosis through β-Catenin-Regulated Cell Apoptosis

    The authors induced human umbilical cord (hUC)-MSCs to differentiate into type 2 alveolar epithelial cells (AEC2s), and provided evidence that intratracheal transplantation of hUC-MSC-derived AEC2s could improve mortality and alleviate fibrosis in bleomycin-induced pulmonary fibrosis mice.
    [Stem Cells and Development]

    Abstract
    Stem Cell Conference Registration Award
    REVIEWS

    Chemokines and Their Receptors: Predictors of the Therapeutic Potential of Mesenchymal Stromal Cells

    Scientists focus on expression of chemokine receptors and chemokine ligands by MSCs isolated from different tissues.
    [Journal of Translational Medicine]

    Full Article
    INDUSTRY AND POLICY NEWS

    Sorrento Announces Positive Results of Phase Ib Study of COVI-MSC™ Treatment of ICU Covid-19 Patients, Achieving 100% (10 out 10) Discharge Rate

    Sorrento Therapeutics, Inc. announced the completion of enrollment in its Phase Ib study of human allogeneic adipose-derived MSCs infusions to treat COVID-19 induced acute respiratory failure or acute respiratory distress syndrome.
    [Sorrento Therapeutics, Inc.]

    Press Release

    Hope Bio’s Stem Cells to Be Used in Fight against Parkinson’s

    Hope Biosciences Stem Cell Research Foundation received FDA authorization for a Phase II clinical trial to assess the efficacy and safety of multiple intravenous infusions of autologous adipose-derived MSCs in improving activities of daily living and quality of life in subjects with Parkinson’s Disease.
    [Hope Biosciences Stem Cell Research Foundation]

    Press Release
    FEATURED EVENT

    Virtual PSC Maintenance and Cell Quality Training Course – May

    May 19 – 21, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Chair – Gastrointestinal and Pancreatic Cancer Research

    Indiana University School of Medicine – Indianapolis, Indiana, United States

    Postdoctoral Researcher Fellowships – Center for Stem Cell and Regenerative Medicine

    Zhejiang University – Zhejiang, China

    Research Assistant – Starstem NanoSTARS

    National University of Ireland Galway – Galway, Ireland

    Postdoctoral Fellow or Research Scientist – Cell and Gene Therapy of Cancer

    Rutgers University – New Brunswick, New Jersey, United States

    Postdoctoral Fellow – Myeloma Tumor Microenvironment

    Moores Cancer Center – La Jolla, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cord Blood News Twitter